New treatment for head and neck cancer in cats using advanced nano-theranostics
Tumor-penetrating nano-theranostics for image-guided interventions in spontaneous feline head and neck cancer
This study is looking at new tiny treatments that can help cats with head and neck cancer by delivering medicine right to the tumor while protecting healthy tissue, which could lead to better recovery and outcomes for these furry friends.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-10824388 on NIH RePORTER |
What this research studies
This research focuses on developing innovative nano-theranostic agents to improve the treatment of head and neck squamous cell carcinoma (HNSCC) in cats. The approach involves creating transformable nanoparticles that can penetrate tumors more effectively and deliver targeted therapy while minimizing damage to surrounding healthy tissues. By utilizing advanced imaging techniques, the study aims to enhance surgical outcomes by accurately identifying and eliminating residual cancerous cells. This could lead to better prognoses for feline patients suffering from this aggressive cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are domestic cats diagnosed with head and neck squamous cell carcinoma.
Not a fit: Cats with other types of cancers or those not diagnosed with head and neck squamous cell carcinoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve treatment outcomes and survival rates for cats diagnosed with head and neck cancer.
How similar studies have performed: While this approach is innovative, similar research has shown promise in using nano-theranostics for cancer treatment in other species, indicating potential for success in this novel application.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Li, Yuanpei — University of California at Davis
- Study coordinator: Li, Yuanpei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.